PARV4 Co-infection is associated with disease progression in HBV patients in Shanghai

Xuelian Yu, Jiayu Wang, Baihui Zhao, Reena GHILDYAL

Research output: Contribution to journalArticle

Abstract

Human parvovirus 4 (PARV4) has been detected in blood and tissue samples from HIV/AIDS patients who are injecting drug users and we have reported PARV4 co-infection of hepatitis B or hepatitis C virus (HBV, HCV) infected individuals. In this study, we have investigated the consequences of co-infection with PARV4 for HBV infected individuals. The aim of this study was to investigate the consequences of co-infection with PARV4 for HBV infected individuals. Serum samples from healthy controls and HBV infected subjects were retrieved from Shanghai Center for Disease Control and Prevention Sample Bank. HBV genotypes were determined and sequences compared with reference sequences to derive phylogeny trees. All samples were tested for PARV4, parvovirus B19 and HCV; serum alanine transaminase (ALT) in chronic HBV patients was used as an indicator of disease severity. Relevant cytokines were measured in sera from healthy controls and HBV carriers. HBV infected subjects had higher prevalence of PARV4 compared to healthy controls. PARV4 prevalence wasnot associated with HBV genotype, negatively correlated with serum HBV DNA, but positively correlated with serum ALT level. Additionally, serum IL-8 was up-regulated in HBV carriers co-infected with PARV4. Co-infection with PARV4 may increase the risk of liver disease in HBV patients through up-regulation of inflammatory cytokines, but the underlying mechanism remains to be elucidated
Original languageEnglish
Pages (from-to)1-8
Number of pages8
JournalJournal of Medical Diagnostic Methods
Volume1
DOIs
Publication statusPublished - 2015

Fingerprint

Parvovirus
Coinfection
Disease Progression
Serum
Alanine Transaminase
Genotype
Cytokines
Phylogeny
Centers for Disease Control and Prevention (U.S.)
Drug Users
Hepatitis B
Interleukin-8
Hepacivirus
Liver Diseases
Acquired Immunodeficiency Syndrome
Up-Regulation
HIV

Cite this

@article{fdba9dc8bed347a6be95fa7f173e63d5,
title = "PARV4 Co-infection is associated with disease progression in HBV patients in Shanghai",
abstract = "Human parvovirus 4 (PARV4) has been detected in blood and tissue samples from HIV/AIDS patients who are injecting drug users and we have reported PARV4 co-infection of hepatitis B or hepatitis C virus (HBV, HCV) infected individuals. In this study, we have investigated the consequences of co-infection with PARV4 for HBV infected individuals. The aim of this study was to investigate the consequences of co-infection with PARV4 for HBV infected individuals. Serum samples from healthy controls and HBV infected subjects were retrieved from Shanghai Center for Disease Control and Prevention Sample Bank. HBV genotypes were determined and sequences compared with reference sequences to derive phylogeny trees. All samples were tested for PARV4, parvovirus B19 and HCV; serum alanine transaminase (ALT) in chronic HBV patients was used as an indicator of disease severity. Relevant cytokines were measured in sera from healthy controls and HBV carriers. HBV infected subjects had higher prevalence of PARV4 compared to healthy controls. PARV4 prevalence wasnot associated with HBV genotype, negatively correlated with serum HBV DNA, but positively correlated with serum ALT level. Additionally, serum IL-8 was up-regulated in HBV carriers co-infected with PARV4. Co-infection with PARV4 may increase the risk of liver disease in HBV patients through up-regulation of inflammatory cytokines, but the underlying mechanism remains to be elucidated",
keywords = "gastroenterology, emerging viruses",
author = "Xuelian Yu and Jiayu Wang and Baihui Zhao and Reena GHILDYAL",
year = "2015",
doi = "10.4172/2168-9784.1000.168",
language = "English",
volume = "1",
pages = "1--8",
journal = "Journal of Medical Diagnostic Methods",
issn = "2168-9784",

}

PARV4 Co-infection is associated with disease progression in HBV patients in Shanghai. / Yu, Xuelian; Wang, Jiayu; Zhao, Baihui; GHILDYAL, Reena.

In: Journal of Medical Diagnostic Methods, Vol. 1, 2015, p. 1-8.

Research output: Contribution to journalArticle

TY - JOUR

T1 - PARV4 Co-infection is associated with disease progression in HBV patients in Shanghai

AU - Yu, Xuelian

AU - Wang, Jiayu

AU - Zhao, Baihui

AU - GHILDYAL, Reena

PY - 2015

Y1 - 2015

N2 - Human parvovirus 4 (PARV4) has been detected in blood and tissue samples from HIV/AIDS patients who are injecting drug users and we have reported PARV4 co-infection of hepatitis B or hepatitis C virus (HBV, HCV) infected individuals. In this study, we have investigated the consequences of co-infection with PARV4 for HBV infected individuals. The aim of this study was to investigate the consequences of co-infection with PARV4 for HBV infected individuals. Serum samples from healthy controls and HBV infected subjects were retrieved from Shanghai Center for Disease Control and Prevention Sample Bank. HBV genotypes were determined and sequences compared with reference sequences to derive phylogeny trees. All samples were tested for PARV4, parvovirus B19 and HCV; serum alanine transaminase (ALT) in chronic HBV patients was used as an indicator of disease severity. Relevant cytokines were measured in sera from healthy controls and HBV carriers. HBV infected subjects had higher prevalence of PARV4 compared to healthy controls. PARV4 prevalence wasnot associated with HBV genotype, negatively correlated with serum HBV DNA, but positively correlated with serum ALT level. Additionally, serum IL-8 was up-regulated in HBV carriers co-infected with PARV4. Co-infection with PARV4 may increase the risk of liver disease in HBV patients through up-regulation of inflammatory cytokines, but the underlying mechanism remains to be elucidated

AB - Human parvovirus 4 (PARV4) has been detected in blood and tissue samples from HIV/AIDS patients who are injecting drug users and we have reported PARV4 co-infection of hepatitis B or hepatitis C virus (HBV, HCV) infected individuals. In this study, we have investigated the consequences of co-infection with PARV4 for HBV infected individuals. The aim of this study was to investigate the consequences of co-infection with PARV4 for HBV infected individuals. Serum samples from healthy controls and HBV infected subjects were retrieved from Shanghai Center for Disease Control and Prevention Sample Bank. HBV genotypes were determined and sequences compared with reference sequences to derive phylogeny trees. All samples were tested for PARV4, parvovirus B19 and HCV; serum alanine transaminase (ALT) in chronic HBV patients was used as an indicator of disease severity. Relevant cytokines were measured in sera from healthy controls and HBV carriers. HBV infected subjects had higher prevalence of PARV4 compared to healthy controls. PARV4 prevalence wasnot associated with HBV genotype, negatively correlated with serum HBV DNA, but positively correlated with serum ALT level. Additionally, serum IL-8 was up-regulated in HBV carriers co-infected with PARV4. Co-infection with PARV4 may increase the risk of liver disease in HBV patients through up-regulation of inflammatory cytokines, but the underlying mechanism remains to be elucidated

KW - gastroenterology

KW - emerging viruses

U2 - 10.4172/2168-9784.1000.168

DO - 10.4172/2168-9784.1000.168

M3 - Article

VL - 1

SP - 1

EP - 8

JO - Journal of Medical Diagnostic Methods

JF - Journal of Medical Diagnostic Methods

SN - 2168-9784

ER -